Current issues: Women and bipolar disorder

Dialogues in Clinical Neuroscience

Volumn 10, Issue 2, 2008, Pages 229-238

  Marangell, Lauren B ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Bipolar disorder; Lactation; Postpartum; Pregnancy; Women

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; FOLIC ACID; LAMOTRIGINE; LITHIUM; OMEGA 3 FATTY ACID; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; VALPROATE SEMISODIUM; VALPROIC ACID;

ANEMIA; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIRTH DEFECT; BODY WEIGHT; BREAST FEEDING; CARDIOVASCULAR MALFORMATION; CLEFT PALATE; CONGENITAL MALFORMATION; CONTRACEPTION; CRANIOFACIAL MALFORMATION; DEHYDRATION; DEVELOPMENTAL DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG INDUCED DISEASE; DRUG SAFETY; EBSTEIN ANOMALY; ELECTROCONVULSIVE THERAPY; ENDOCRINE FUNCTION; EPILEPSY; FACE MALFORMATION; FETAL VAPROATE SYNDROME; FOLLOW UP; GENDER; GROWTH RETARDATION; HEALTH CARE PLANNING; HEALTH PROGRAM; HEART DISEASE; HUMAN; HYDRAMNIOS; HYPERANDROGENISM; HYPERPROLACTINEMIA; HYPOTHERMIA; HYPOTHYROIDISM; INFANTILE HYPOTONIA; LACTATION; LETHARGY; MANIA; MENSTRUATION; MICROCEPHALY; MONOTHERAPY; MUSCLE HYPOTONIA; NEONATAL HEMORRHAGE; NEPHROGENIC DIABETES INSIPIDUS; NEURAL TUBE DEFECT; OLIGOMENORRHEA; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; PREGNANCY; PREMATURE LABOR; PREVALENCE; PSYCHOTHERAPY; PUERPERIUM; REPRODUCTIVE HEALTH; RESPIRATORY TRACT MALFORMATION; RISK ASSESSMENT; SEX DIFFERENCE; SIDE EFFECT; SPINA BIFIDA; SPONTANEOUS ABORTION; STILLBIRTH; T WAVE; TERATOGENESIS; THROMBOCYTOPENIC PURPURA; THYROID DISEASE; THYROIDITIS; TREATMENT RESPONSE; URINARY TRACT MALFORMATION; UROGENITAL TRACT MALFORMATION;

ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DEPRESSION, POSTPARTUM; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; HYPOTHYROIDISM; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 47749125775     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Regier DA, Myers JK, Kramer M, et al. The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry. 1984;41:934-941.
2. Kessler RC, Berglund P, Demler O, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602.
3. Kessler, RC, Chiu, WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627.
4. Goodwin FK, Jamison KR. Suicide. In: Goodwin FK, Jamison KR, eds. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990:227-244.
5. Roy-Byrne P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal course of affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand. 1985;71(suppl 317):1-34.
6. Tondo L, Baldessarini RJ. Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry. 1998;155:1434-1436.
7. Robb JC, Young LT, Cooke RG, Joffe RT. Gender differences in patients with bipolar disorder influence outcome in the medical outcomes survey (SF-20) subscale scores. J Affect Disord. 1998;49:189-193.
8. Schneck CD, Miklowitz DJ, Calabrese JR, et al. Phenomenology of rapid cycling bipolar disorder: Data from the first 500 participants in the systematic treatment enhancement program for bipolar disorder. Am J Psychiatry. 2004;161:1902-1908.
9. Akiskal HS, Hantouche EG, Bourgeois ML et al. Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). J Affect Disord. 1998;50:175-186.
10. Freeman MP, McElroy SL. Clinical picture and etiologic models of mixed states. Psychiatr Clin N Am. 1999;22:535-546, vii.
11. Arnold LM, McElroy SL, Keck PE Jr. The role of gender in mixed mania. Compr Psychiatry. 2000;41:83-87.
12. McElroy SL, Keck PE, Jr, Pope HG, Jr, Hudson JI, Faedda GL, Swann AC. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry. 1992;149:1633-1644.
13. Leibenluft E. Issues in the treatment of women with bipolar illness. J Clin Psychiatry. 1997;58(suppl 15):5-11.
14. Burt VK, Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disord. 2004:6:2-13.
15. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356:1711-1722.
16. Blehar MC, DePaulo JR Jr, Gershon ES, Reich T, Simpson SG, Nurnberger JI Jr. Women with bipolar disorder: findings from the NIMH Genetics Initiative sample. Psychopharmacol Bull. 1998;34:239-243.
17. Rasgon N, Bauer M, Glenn T, Elman S, Whybrow PC. Menstrual cycle related mood changes in women with bipolar disorder. Bipolar Disord. 2003;5:48-52.
18. Hendrick V, Altshuler LL, Burt VK. Course of psychiatric disorders across the menstrual cycle. Harv Rev Psychiatry. 1996;4:200-207.
19. Ishimaru-Tseng TV. Evaluation of late onset bipolar illness during menopause. Hawaii Med J. 2000;59:51-53.
20. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol. 1980;13:156-167
21. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini, RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000;157:179-184.
22. Bratfos O, Haug JO. Puerperal mental disorders in manic-depressive females. Acta Psychiatr Scand. 1966;42:285-294.
23. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry. 1987;150:662-673.
24. Reich T, Winokur G. Postpartum psychosis in patients with manic depressive disease. J Nerv Ment Dis. 1970;151:60-68.
25. Jefferson JW, Greist JH, Ackerman DL, Carroll JA. Pregnancy. In: Lithium Encyclopedia for Clinical Practice. Washington, DC: American Psychiatric Press, Inc; 1987: 504-511.
26. Freeman M, Smith K, Freeman S, McElroy S, Kmetz G, Wright R, Keck P: The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63:284-287.
27. Pariser SF. Women and mood disorders, menarche to menopause. Ann Clin Psychiatry. 1993;5:249-254.
28. Miller LJ. Postpartum depression. JAMA. 2002;287:762-765.
29. Viguera AC, Tondo L, Baldessarini RJ. Sex differences in response to lithium treatment. Am J Psychiatry. 2000;157:1509-1511.
30. Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med. 2001;52:401-419.
31. Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853-861.
32. Lobo RA, Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med. 2000;132:989-993.
33. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, eds. Polycystic Ovary Syndrome. Oxford, UK: Blackwell Scientific; 1992:377-384.
34. Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078-3082.
35. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, et al. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med. 1993;329:1383-1388.
36. Isojarvi JI, Rattya J, Myllyla VV, et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol. 1998;43:446-451.
37. Rasgon NL, Altshuler LL, Gudeman D, et al. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. J Clin Psychiatry. 2000;61:173-78.
38. Rasgon NL, Altshuler LL, Fairbanks L, et al. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord. 2005:7:246-259.
39. McIntyre RS, Mancini DA, McCann S, et al. Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord. 2003;5:28-35.
40. Joffe H, Cohen LS, Suppes T, et al. Valproate is associated with newonset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry. 2006;59:1078-1086.
41. Joffe H, Cohen LS, Suppes T, et al. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features. Biol Psychiatry. 2006;60:1378-1381
42. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med. 327:765-771.
43. Morrell MJ, Giudice L, Flynn KL, et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol. 2002;52:704-711.
44. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986;62:904-910.
45. Castillo-Martinez L, Lopez-Alvarenga JC, Villa AR, Gonzalez-Barranco J. Menstrual cycle length disorders in 18- to 40-y-old obese women. Nutrition. 2003;19:317-320.
46. Peppard HR, Marfori J, Iuorno MJ, Nestler JE. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care. 2001;24:1050-1052.
47. Yeshaya A, Orvieto R, Dicker D, Karp M, Ben-Rafael Z. Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J Fertil Menopausal Stud. 1995;40:269-273.
48. Rasgon, N. The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. J Clin Psychopharmacol. 2004;24:322-334.
49. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry. 1999;175:336-339.
50. Viguera AC, Cohen LS, Bouffard S, Whitfield TH, Baldessarini RJ. Reproductive Decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry. 2002;159:2102-2104.
51. Centers for Disease Control: Valproate: a new cause of birth defects - report from Italy and follow-up from France. MMWR Morb Mortal Wkly Rep. 1983;32:438-439.
52. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A reevaluation of risk of in utero exposure to lithium. JAMA. 1994;271:146-150.
53. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med. 1991;324:674-677.
54. Yonkers KA, Wisner KL, Stowe Z, et al Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004;161:608-620.
55. Freeman MP, Gelenberg AJ. Bipolar disorder in women: reproductive events and treatment considerations. Acta Psychiatr Scand. 2005;112:88-96.
56. Gentile S. Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disord. 2006;8:207-220.
57. McElroy SL. Bipolar disorders: Special diagnostic and treatment considerations in women. CNS Spectr. 2004;9 (suppl 7):5-18.
58. Lamberg L. Risks and benefits key to psychotropic use during pregnancy and postpartum period. JAMA. 2005:294:1604-1608.
59. Grof P, Robbins W, Alda M, et al. Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord. 2000;61:31-39
60. Stewart DE, Klompenhouwer JL, Kendell RE, van Hulst AM. Prophylactic lithium in puerperal psychosis. The experience of three centres. Br J Psychiatry. 1991;158:393-397.
61. Viguera AC, Cohen LS. The course and management of bipolar disorder during pregnancy. Psychopharmacol Bull. 1998;34:339-346.
62. Cohen LS, Sichel DA, Robertson LM, Heckscher E, Rosenbaum JF. Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry. 1995;152:1641-1645.
63. Austin MP. Puerperal affective psychosis: is there a case for lithium prophylaxis? Br J Psychiatry. 1992;161:692-694.
64. Stewart DE. Prophylactic lithium in postpartum affective psychosis. J Nerv Ment Dis. 1988;176:485-489.
65. Wisner KL, Hanusa BH, Peindl KS, Perel JM. Prevention of postpartum episodes in women with bipolar disorder. Biol Psychiatry. 2004;56:592-596.
66. Crawford MA, Hassam AG, Stevens PA. Essential fatty acid requirements in pregnancy and lactation with special reference to brain development. Prog Lipid Res. 1981;20:31-40.
67. Connor WE & Neuringer M. The effects of n-3 fatty acid deficiency and repletion upon the fatty acid composition and function of the brain and retina. Prog Clin Biol Res. 1988;282:275-294.
68. Kubow S, Koski KG. Maternal dietary glucose-lipid interactions modulate embryological development in vivo and in embryo culture. Biol Reprod. 1995;52:145-155.
69. High KA, Kubow S. n-3 Fatty acids inhibit defects and fatty acid changes caused by phenytoin in early gestation in mice. Lipids. 1994;11:771-778.
70. Hornstra G, van Houwelingen AC, Foreman-van Drongelen MM. Essential fatty acids in pregnancy and early human development. Eur J Obstet Gynecol Reprod Biol. 1995;61:57-62.
71. Glozman S, Green P, Kamensky B, Weiner L, Yavin E. Ethyl docosahexaenoic acid administration during intrauterine life enhances prostanoid production and reduces free radicals generation in the fetal rat brain. Lipids. 1999;34(suppl):S247-S248.
72. Holman RT, Johnson SB, Ogburn PL. Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci U S A. 1991;88:4835-4839.
73. Min Y, Ghebremeskel K, Crawford MA, et al. Pregnancy reduces arachidonic and docosahexaenoic in plasma triacylglycerols of Korean women. Int J Vitam Nutr Res. 2000;70:70-75.
74. Otto SJ, van Houwelingen AC, Antal M, et al. Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur J Clin Nutr. 1997;51:232-242.
75. Hibbeln JR, Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr. 1995;62:1-9.
76. Benisek D, Shabert J, Skornik R. Dietary intake of polyunsaturated fatty acids by pregnant or lactating women in the United States. Obstet Gynecol. 2000;95:77-78.
77. Glueck CJ, Streicher P, Wang P, Sprecher D, Falko JM. Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids. Nutrition. 1996;12:202-205.
78. Bulstra-Ramakers MT, Huisjes HJ, Visser GH. The effects of 3g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. Br J Obstet Gynaecol. 1995;102:123-126.
79. Onwude JL, Lilford RJ, Hjartardottir H, Staines A, Tuffnell D. A randomized double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynecol. 1995;102:95-100.
80. Marangell LB, Suppes T, Ketter TA, et al. Omega-3 fatty acids in bipolar disorder: clinical and research considerations. Prostaglandins, Leukot Essent Fatty Acids. 2006;75:315-321.
81. Miklowitz, DJ, Otto MW, Frank, E. Psychosocial treatments for bipolar depression: a 1-Year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry. 2007;64:419-426.
82. Spinelli MG. Interpersonal psychotherapy for depressed antepartum women: a pilot study. Am J Psychiatry. 1997;154:1028-1030.
83. Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ. 1997;12:932-937.
84. Segre LS, Stuart S, O'Hara MW. Interpersonal psychotherapy for antenatal and postpartum depression. Primary Psychiatry. 2004;11:52-66.
85. Jones S. Psychotherapy of bipolar disorder: a review. J Affect Disord. 2004;80:101-114.
86. Llewellyn A, Stowe ZN, Strader JR, et al. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry. 1998;59(suppl 6):57-64.
87. Miller LJ. Use of electroconvulsive shock therapy during pregnancy. Hosp Community Psychiatry. 1994;45:444-450.